Literature DB >> 20934355

Pulmonary embolism in pediatric patients survey of CT pulmonary angiography practices and policies.

Edward Y Lee1, David Zurakowski, Phillip M Boiselle.   

Abstract

RATIONALE AND
OBJECTIVES: To determine the current policies and practices of Society for Pediatric Radiology (SPR) members regarding the evaluation of pediatric patients with suspected pulmonary embolism (PE) with an emphasis on use of computed tomography pulmonary angiography (CTPA).
MATERIALS AND METHODS: Institutional review board exemption was granted for this study. Surveys were mailed electronically to the 1575 members of the SPR representing 416 institutions. Information gathered included the existence of written policies, the imaging study of choice for suspected PE, routine acquisition of chest radiographs before CTPA, currently used CTPA techniques, modifications of protocols for radiation dose reduction, typical DLP (dose-length-product) for CTPA, and estimated annual frequency of performing CTPA for evaluating PE in children. Survey items pertaining to policies and practices were compared between practice settings and populations using chi-square analysis.
RESULTS: One hundred and sixty members representing 118 institutions responded, which resulted in a response rate of 28% (118/416), on an institutional basis. Of these 118 respondents, 104 (88%) perform CTPA in children with clinical suspicion of PE. Of the 104 respondents who perform CTPA, 26 (25%) have a written policy for CTPA, 93 (89%) perform CTPA as the first study choice, and 67 (64%) routinely obtain chest radiographs before CTPA. The most commonly used CTPA techniques in children with clinical suspicion of PE include intravenous contrast amount of 2 mL/kg, mechanical injection of intravenous contrast, and tailored bolus tracking method for CTPA scan initiation by observing the Hounsfield units of contrast in the central pulmonary artery on the monitoring scan. Sixty respondents (58%) modify CTPA imaging protocols for evaluating PE in children in order to decrease radiation dose. The two most common modifications for radiation dose reduction were reduced mAs in 41 (68%) and automatic exposure control in 38 (63%). The majority of respondents (88%) did not know the typical DLP for a 20-kg child during CTPA study performed to evaluate for PE. A significantly greater percentage of radiation dose-reduction techniques are performed within academic institutions compared with private institutions (P = .03).
CONCLUSION: Most survey respondents perform CTPA as the study of choice for evaluating PE in children, but there is considerable variability in their policies and practices. Respondents from academic medical centers are more likely to employ radiation dose-reduction techniques for CTPA than those in private practice settings.
Copyright © 2010 AUR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20934355     DOI: 10.1016/j.acra.2010.08.012

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  4 in total

Review 1.  Newer CT applications and their alternatives: what is appropriate in children?

Authors:  R Paul Guillerman
Journal:  Pediatr Radiol       Date:  2011-08-17

Review 2.  Multidetector computed tomography pulmonary angiography in childhood acute pulmonary embolism.

Authors:  Chun Xiang Tang; U Joseph Schoepf; Shahryar M Chowdhury; Mary A Fox; Long Jiang Zhang; Guang Ming Lu
Journal:  Pediatr Radiol       Date:  2015-04-07

3.  Clinical variables that increase the probability of pulmonary embolism diagnosis in symptomatic children.

Authors:  Kara E Hennelly; Angela M Ellison; Mark I Neuman; Jeffrey A Kline
Journal:  Res Pract Thromb Haemost       Date:  2019-10-26

Review 4.  Computed tomography and magnetic resonance imaging for pulmonary embolus evaluation in children: up-to-date review on practical imaging protocols.

Authors:  Andrew Z Liu; Abbey J Winant; Lina K Lu; Vanessa Rameh; Kevin Byun; Edward Y Lee
Journal:  Pediatr Radiol       Date:  2022-07-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.